[{"data":1,"prerenderedAt":135},["ShallowReactive",2],{"naujienos/following-annual-growth-of-87-lithuanias-biotech-sector-is-focusing-on-building-international-connections/en":3},{"status":4,"data":5},true,{"image":6,"id":14,"seo":15,"title":12,"date":90,"url":86,"fullUrl":26,"text":91,"excerpt":25,"more":92,"tags":133,"temos":134},{"src":7,"is_svg":8,"ratio":9,"width":10,"height":11,"alt":12,"caption":13},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2021/08/shutterstock-1708898095-580x430-1.jpg",false,0.7413793103448276,580,430,"Following annual growth of 87%, Lithuania’s Biotech sector is focusing on building international connections","",7109,{"title":16,"robots":17,"og_locale":23,"og_type":24,"og_title":16,"og_description":25,"og_url":26,"og_site_name":27,"article_publisher":28,"og_image":29,"twitter_card":34,"schema":35,"breadcrumbs":78,"description":13,"language":87},"Following annual growth of 87%, Lithuania’s Biotech sector is focusing on building international connections - Inovacijų agentūra",{"index":18,"follow":19,"max-snippet":20,"max-image-preview":21,"max-video-preview":22},"index","follow","max-snippet:-1","max-image-preview:large","max-video-preview:-1","en_US","article","In 2020, Biotech accounted for 2.5 per cent of Lithuania’s GDP, equating to year-on-year growth of 87 per cent. This thriving sector provides opportunities for further international cooperation in the field of Life Sciences.","https://www.inovacijuagentura.lt/en/naujiena/following-annual-growth-of-87-lithuanias-biotech-sector-is-focusing-on-building-international-connections/","Inovacijų agentūra","https://www.facebook.com/inovacijuagentura",[30],{"width":31,"height":32,"url":7,"type":33},"580","430","image/jpeg","summary_large_image",{"@context":36,"@graph":37},"https://schema.org",[38,53,55,65,69],{"@type":39,"@id":26,"url":26,"name":16,"isPartOf":40,"primaryImageOfPage":42,"image":44,"thumbnailUrl":7,"datePublished":45,"breadcrumb":46,"inLanguage":48,"potentialAction":49},"WebPage",{"@id":41},"https://www.inovacijuagentura.lt/en/#website",{"@id":43},"https://www.inovacijuagentura.lt/en/naujiena/following-annual-growth-of-87-lithuanias-biotech-sector-is-focusing-on-building-international-connections/#primaryimage",{"@id":43},"2021-08-31T12:22:00+00:00",{"@id":47},"https://www.inovacijuagentura.lt/en/naujiena/following-annual-growth-of-87-lithuanias-biotech-sector-is-focusing-on-building-international-connections/#breadcrumb","en-US",[50],{"@type":51,"target":52},"ReadAction",[26],{"@type":54,"inLanguage":48,"@id":43,"url":7,"contentUrl":7,"width":31,"height":32,"caption":12},"ImageObject",{"@type":56,"@id":47,"itemListElement":57},"BreadcrumbList",[58,63],{"@type":59,"position":60,"name":61,"item":62},"ListItem","1","Home","https://www.inovacijuagentura.lt/en/",{"@type":59,"position":64,"name":12},"2",{"@type":66,"@id":41,"url":62,"name":27,"description":13,"publisher":67,"inLanguage":48},"WebSite",{"@id":68},"https://www.inovacijuagentura.lt/en/#organization",{"@type":70,"@id":68,"name":27,"url":62,"logo":71,"image":76,"sameAs":77},"Organization",{"@type":54,"inLanguage":48,"@id":72,"url":73,"contentUrl":73,"width":74,"height":75,"caption":27},"https://www.inovacijuagentura.lt/en/#/schema/logo/image/","https://web-prod.inovacijuagentura.lt/wp-content/uploads/2026/05/ia-logo-main.svg","1886","786",{"@id":72},[28],[79,82,85],{"url":80,"text":61,"id":81},"/en/",7576,{"url":83,"text":84},"/en/news/","News",{"url":86,"text":12,"id":14},"/en/naujiena/following-annual-growth-of-87-lithuanias-biotech-sector-is-focusing-on-building-international-connections/",[88],{"url":26,"code":89,"locale":89,"default":8},"en","2021-08-31","\u003Cp>A 900% increase in Biotech revenue between 2010 and 2020 places Lithuania among Europe‘s fastest-growing Life Sciences destinations. With the aim of achieving 5 per cent of GDP share by 2030, the country‘s Biotech community is focused on attracting investments and securing stable government support.\u003C/p>\n\u003Cp>In a country of 2.8 million citizens, six universities offer study programmes in Biotech-related fields, while 2,500 people work in the private Biotech sector alone. Lithuania has already achieved Biotech success in the US, Germany, and the UK markets, where Lithuanian companies are developing gene-editing, drug discovery and clinical trial solutions.\u003C/p>\n\u003Cp>Among the institutions driving the sector forward are the Lithuanian Biotechnology Association (LBTA) and the governmental agency Enterprise Lithuania, responsible for connecting Lithuanian companies with stakeholders abroad.\u003C/p>\n\u003Cp>In 2012, Enterprise Lithuania organised the first edition of Life Sciences Baltics forum in Vilnius. The event helped attract the most influential people from the sector. Now, Life Sciences Baltics is an exclusive event that enables world-class experts to meet the emerging leaders from the fast-growing Baltic Life Sciences hub together in one place. This year, the forum will take place on 20-24 September, and features an international conference with keynotes, panel discussions and company presentations, a startup pitch battle, virtual exhibition and B2B meetings.\u003C/p>\n\u003Cp>The conference programme will highlight the areas in which Baltic Life Sciences excel – digital health, gene editing, MedTech, early drug discovery, imaging, personalised medicine and the microbiome. Keynotes include one of the leading minds behind CRISPR-Cas9 gene editing technology, the internationally renowned Lithuanian researcher Prof. Dr Virginijus Šikšnys, alongside the 2017 Nobel laureate in Chemistry, Dr Richard Henderson, and the president of AskBio, Katherine High.\u003C/p>\n\u003Cp>\u003Cimg loading=\"lazy\" decoding=\"async\" src=\"https://www.enterpriselithuania.com/wp-content/uploads/2021/06/Es_logo-color_200px.png\" width=\"200\" alt=\"\" height=\"56\" />\u003C/p>\n\u003Ch2> \u003C/h2>\n",[93,102,111,125],{"image":94,"title":97,"url":98,"id":99,"text":100,"temos":101},{"src":95,"is_svg":8,"ratio":96,"alt":97,"caption":13},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2026/05/kosmoso-memorandumas-su-polsa.jpg",0.6669921875,"Lithuania Strengthens Cooperation with Poland and the United States in the Space Sector: Important Memorandums Signed","/en/naujiena/lithuania-strengthens-cooperation-with-poland-and-the-united-states-in-the-space-sector-important-memorandums-signed/",6748,"Lithuania’s space sector continues to strengthen international partnerships and expand cooperation with key players in the global space industry. Innovation Agency Lithuania has recently signed two significant memorandums of understanding – with the Polish Space Agency (POLSA) and the U.S. space infrastructure company Vast. These agreements open new opportunities for Lithuanian businesses, research institutions, and international projects.",[],{"image":103,"title":106,"url":107,"id":108,"text":109,"temos":110},{"src":104,"is_svg":8,"ratio":105,"alt":106,"caption":13},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2026/03/shutterstock-2539768243-1.jpg",0.7490234375,"Lithuania Ranks First in Europe in the Global Entrepreneurship Index","/en/naujiena/lithuania-ranks-first-in-europe-in-the-global-entrepreneurship-index/",6892,"The latest Global Entrepreneurship Monitor (GEM) 2025/2026 global report shows that Lithuania is the leading country in Europe in terms of the quality of its entrepreneurial environment and ranks among the world’s strongest economies in this field.",[],{"image":112,"title":114,"url":115,"id":116,"text":117,"temos":118},{"src":113,"is_svg":8,"ratio":96,"alt":114,"caption":13},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2026/01/karolina-urbonaite.jpg","Lithuania’s Startup Ecosystem Surpasses €16.4 Billion in Value: Investments Jump 1.7x in 2025","/en/naujiena/lithuanias-startup-ecosystem-surpasses-e16-4-billion-in-value-investments-jump-1-7x-in-2025/",6999,"The total value of Lithuania’s startup ecosystem reached €16.4 billion in 2025, according to the latest Dealroom report initiated by Startup Lithuania, a division of the Innovation Agency. In just one year, Lithuanian startups attracted €220 million in venture capital investments from 77 unique investors. The ecosystem’s growing maturity was further confirmed earlier this year with the addition of a new unicorn to Lithuania’s startup map — Cast AI.",[119,122],{"id":120,"name":121},577,"Growth",{"id":123,"name":124},579,"Innovation",{"image":126,"title":128,"url":129,"id":130,"text":131,"temos":132},{"src":127,"is_svg":8,"ratio":96,"alt":128,"caption":13},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2025/12/modix-fgf-3d-spausdintuvas-2.jpg","Mission-Driven Innovations: Science and Business Shaping Lithuania’s Future","/en/naujiena/mission-driven-innovations-science-and-business-shaping-lithuanias-future/",6904,"Some important scientific research activities and innovative business-developed products may sound complex – unsurprisingly, as they are developed by people who dedicate their entire lives to these fields. Yet behind these sophisticated terms lie concrete solutions that will eventually make each of our daily lives easier. Where science and business join forces, more accurate disease diagnostics for the health of us and our loved ones are developed, cybersecurity tools are created to protect the country, and climate-neutral production technologies and materials emerge to help preserve our nature and resources.",[],[],[],1780325206029]